OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
OncClub: Join the Chat on Trending Trials in CancerComplimentary print subscription for home or office deliveryIn-person and virtual events just for HCPsLively expert panel discussions featuring peer-to-peer exchangesSubscribe to our eNewsletter for breaking news and curated content
Specialty
View MoreBreast CancerCAR T-cell TherapyChronic Lymphocytic LeukemiaGastrointestinal CancerGenitourinary CancersGynecologic OncologyImmuno-OncologyLung CancerMelanoma & Skin CancerMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • OncClub: Join the Chat on Trending Trials in Cancer
  • Complimentary print subscription for home or office delivery
  • In-person and virtual events just for HCPs
  • Lively expert panel discussions featuring peer-to-peer exchanges
  • Subscribe to our eNewsletter for breaking news and curated content
SpecialtySee All >
  • Breast Cancer
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Gynecologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Recent Advances in Treatment of Acute Myeloid Leukemia

EP. 1: Molecular Testing for AML

January 28th 2020

EP. 2: AML Induction Strategy and Molecular Testing

January 28th 2020

EP. 3: Assessment of Fitness for AML Induction Chemotherapy

January 28th 2020

EP. 4: Decision Making on Consolidation Therapy for AML

January 28th 2020

EP. 5: QUAZAR: Oral Azacitidine Maintenance in AML

January 28th 2020

EP. 6: Hypomethylating Agents for AML

January 28th 2020

EP. 7: Venetoclax-Based Regimens for Unfit Patients with AML

January 28th 2020

EP. 8: Managing Venetoclax-Associated Toxicity in AML

January 28th 2020

EP. 9: Venetoclax-Based Chemotherapy Combinations in AML

January 28th 2020

EP. 10: CPX-351 for Secondary AML

January 28th 2020

EP. 11: Previously Untreated FLT3-Mutated AML

January 28th 2020

EP. 12: Second-Generation FLT3 Inhibitors for AML

January 28th 2020

EP. 13: Relapsed/Refractory FLT3-Mutated AML

January 28th 2020

EP. 14: IDH1/2 Inhibitors in AML

January 28th 2020

EP. 15: Differentiation Syndrome and IDH1/2 Inhibitors

January 28th 2020

EP. 16: Gemtuzumab Ozogamicin for CD33+ AML and APL

January 28th 2020

EP. 17: Immune Checkpoint Inhibitors for AML

January 28th 2020

EP. 18: Novel Agents Under Investigation for AML

January 28th 2020